We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




How Exactly Does Bleach Manage To Kill Bacteria?

By HospiMedica International staff writers
Posted on 26 Nov 2008
A new study suggests that the antimicrobial effects of common bleach are largely based on its ability to cause aggregation of essential bacterial proteins.

Researchers at the University of Michigan (Ann Arbor, MI, USA) have discovered how Hypochlorous acid (HOCl), the active ingredient in household bleach, manages to be such an effective antimicrobial agent. More...
The researchers had been studying a bacterial protein called heat shock protein 33 (Hsp33), which is a kind of molecular chaperon that becomes active when cells are in distress. In this case, the source of the distress was HOCl. When they exposed the bacteria to the bleach, the heat shock protein became active by the reversible oxidative unfolding of its C-terminal redox switch domain, turning the inactive Hsp33 into a highly active chaperone holdase, which protects essential Escherichia coli proteins by forming clumps in an attempt to protect other proteins in the bacteria from losing their chemical structure. The researchers explained that the human immune system also produces HOCl in response to infection, but that the substance kills not only the bacterial invaders but human cells as well, which may explain how tissue is destroyed in chronic inflammation, due to the targeting of thermolabile proteins, thereby causing irreversible aggregation. The study was published in the November 14, 2008, issue of the journal Cell.

"Hypochlorous acid is an important part of host defense,” said lead author Associate Professor Ursula Jakob, Ph.D., and colleagues of the department of molecular, cellular, and developmental biology. "It's not just something we use on our countertops.”

Hypochlorous acid is a weak acid that bonds when chlorine dissolves in water. In the body, HOCl is generated in activated neutrophils by peroxidation of chloride ions.

Related Links:
University of Michigan



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.